期刊文献+

姜黄素衍生物L6H4对糖脂代谢异常大鼠的治疗作用及其机制 被引量:5

The therapeutic effect of curcumin derivatives L6H4 on rats with abnormalities of glucose and lipid metabolism and its mechanism
下载PDF
导出
摘要 目的:观察姜黄素衍生物L6H4对糖脂代谢异常大鼠代谢指标的影响,并对其作用机制进行初步探讨。方法:24只8周龄雄性SD大鼠随机分为正常空白对照组(NC组,n=8),高脂组(HF组,n=8)和高脂治疗组(FT组,n=8),后2组高糖高脂饲料喂养12周。第5周时开始给予药物治疗8周,12周末检测各组大鼠血清生化指标、肝脏和骨骼肌的甘油三酯(TG),以及与糖脂代谢相关的多项指标,并观察光镜下肝脏与骨骼肌的病理学变化。结果:1HF组与NC组比较,体质量增加(P<0.05),肝湿质量、空腹血糖(FBG)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOME-IR)、血清TG、肝脏TG、骨骼肌TG、血清ALT、血清游离脂肪酸(FFA)、高敏C反应蛋白(hs-CRP)和白介素6(IL-6)水平均升高(均P<0.01),脂联素(ADP)、瘦素(LEP)下降(分别P<0.01,P<0.05),成纤维细胞生长因子21(FGF-21)差异无统计学意义(P>0.05);2FT组与HF组比较,FINS、肝湿质量与肝指数差异均无统计学意义(P>0.05),体质量、肝脏TG、血TG、ALT、FBG、HOMEIR、FFA、hs-CRP水平降低(P<0.01),骨骼肌TG、IL-6水平下降(P<0.05),FGF-21、ADP升高(P<0.01);3HF组肝脏可见明显脂肪变及炎症细胞浸润,骨骼肌细胞间质可见脂肪浸润,治疗后肝脏脂肪变以及骨骼肌脂肪浸润明显改善。结论:姜黄素衍生物L6H4对高脂高糖喂养大鼠具有控制体质量、保护肝功能、改善胰岛素抵抗的作用,可能与其调脂、抑制炎症、降低异位脂肪存积相关。 Objective: To observe the effect of curcumin derivatives L6H4 on rats with abnormalities of glucose and lipid metabolism, and preliminarily study the mechanism of it. Methods: Twenty-four male SD rats were randomly allocated into three groups: normal control group(NC group, n=8), high fatty group(HF group, n=8), and fatty treatment group(FT group, n=8). To fed the rats in HF group and FT group with high fat and surgar diet for 12 weeks, from the 5th week with drug treatment for 8 weeks, at the end of 12 th week, the following indexes were measured respectively in each group: serum biochemical indexes, liver and skeletal muscle triglycerides, and related indicators of sugar and lipid matabolism. Observing the liver pathological changes at the same time. Results: 1Compared HF group with NC group: weight gain(P〈0.05), liver weight, fasting blood glucose(FBG), fasting insulin(FINS), insulin resistance index(HOME-IR), serum triglycerides, liver triglyceride, skeletal muscle triglycerides, serum ALT, FFA, high-sensitivity c-reactive protein(hs-CRP) and interleukin 6 increased(P〈0.01), adiponectin and leptin decreased(P〈0.01, P〈0.05, respectively). 2Compared the FT group with HF group: weight and ALT loss(P〈0.01), liver weight and liver index had no obvious difference, FBG decreased(P〈0.01), FINS(P〈0.05), the HOME-IR decreased(P〈0.01), serum triglycerides, liver triglycerides and skeletal muscle triglyceride were reduced(P〈0.01, P〈0.01, and P〈0.05, respectively), FFA and hs-CRP reduced(P〈0.01), fibroblast growth factor 21(FGF-21) increased(P〈0.01), adiponectin, interleukin 6 increased with P〈0.01 and P〈0.05, respectively. 3Inflammatory injury in hepatic tissue of HF groups was slight, while fatty degeneration in hepatic tissue and skeletal muscle were obvious, the condition was significantly reduced in the FT group. Conclusion: Curcumin derivatives L6H4 has the effect of controlling weight, protecting the liver function and improving the condition of insulin resistance on high fat and sugar-fed rats.
出处 《温州医学院学报》 CAS 2015年第3期176-179,184,共5页 Journal of Wenzhou Medical College
基金 浙江省公益性技术应用研究计划项目(2011c23123) 温州市高层次人才创新技术项目
关键词 姜黄素衍生物L6H4 胰岛素抵抗 异位脂肪沉积 高脂血症 大鼠 curcumin derivatives L6H4 insulin resistance ectopic fat deposition hyperlipidemia rats
  • 相关文献

参考文献10

  • 1Yang W, Xiao J, Yang Z, et al. Serum lipids and lipoproteins in Chinese men and women[J]. Circulation, 2012, 125(18): 2212-2221.
  • 2张微,程然,张冰,金道龙,季乐丹,王晓.单纯性肥胖儿童糖脂代谢特点及胰岛素抵抗分析[J].温州医学院学报,2007,37(3):280-281. 被引量:1
  • 3Zingg JIM, Hasan ST, Meydani M. Molecular mechanisms of hypolipidemic effects of curcumin[J]. Biofactors, 2013, 39 (1): 101-121.
  • 4Wu JZ, Li JL, Cai YP, et al. Evaluation and Discovery of Novel Synthetic Chalcone Derivatives as Anti-lnflammatory Agents[J]. J Med Chem, 2011, 54: 8110-8123.
  • 5吴亮,吴晓烨,王环,牛三强,王蓉蓉,陈筱菲,方周溪,陈国荣.2型糖尿病大鼠脑内11β-HSD1和GR的表达与认知功能的关系及棉酚的干预作用[J].中国病理生理杂志,2009,25(7):1336-1341. 被引量:10
  • 6Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tis- sues[J]. J Bio Chem, 1957, 226(1): 497-509.
  • 7Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia, 1985, 28: 412-419.
  • 8李启富,刘露路.慢性炎症与异位脂肪沉积[J].中华糖尿病杂志,2013,5(3):132-136. 被引量:2
  • 9卜石,杨文英,王昕,刘雪莉,陈仕明,湛玉良.长期高脂饲养对大鼠葡萄糖刺激的胰岛素分泌的影响[J].中华内分泌代谢杂志,2003,19(1):25-28. 被引量:43
  • 10Iglesias P, Selgas R, Romero S, et al. Biological Role, clini- cal significance and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21 [J]. Eur Soc Endocrinol, 2012, 167(3): 301-309.

二级参考文献57

  • 1Nyrenda MJ,Lindsay KS,Kenyon C J,et al.Glucocortieoid exposure in late gestation permanently programs rat hepatic pbosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and cause glucose intolerance in adult offspring[J].J Clin Invest,1998,101(10):2174-2181.
  • 2De Kloet ER,Vreugdenhil E,Oitzl MS,et al.Brain cortieosteroid receptor balance in health and disease[J].Endocr Rev,1998,19 (3):269-301.
  • 3Jaroszewski JW,Strom-Hansen T,Hansen SH,et al.On the botanical distribution of chiral forms of gessypol[J].Planta Med,1992,58(5):454-458.
  • 4Ge RS,SangGW,Wang MS.The effects ofgessypol acetate and glycyrrehtenic acid on testicular 11 beta-hydroxysteroid dehydrogenase in the rat[J].Chinese Pharmacological Bulletin,1996,12(1):79.
  • 5Yki-Jarvinen H.Role of insulin resistance in the pathogenesis of NIDDM[J].Diabetologia,1995,38 (12):1378-1388.
  • 6Seckl JR.11beta-Hydroxysteroid dehydrogenase in the brain:a novel regulator of glucocortieoid action?[J].Front Neuroendocrinol,1997,18(1):49-99.
  • 7Liu GZ,Lyle KC,Cao J.Experiences with gossypol as a male pill[J].Am J Obstet Gynecol,1987,157(4 Pt 2):1079-1081.
  • 8Stewart PM,Krozowski ZS.11 beta-hydroxysteroid dehydrogenase[J].Vitam Horm,1999,57:249-324.
  • 9Vogt B,Dick B,N'Gankam V,et al.Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotie syndrome[J].J Cli.n Endocrinol Metab,1999,84(2):811-814.
  • 10陈灏珠.实用内科学(上册)[M].第10版.北京:人民卫生出版社,1998.877-899.

共引文献52

同被引文献41

  • 1林清认,周霞.姜黄素对肺癌细胞的放疗增敏作用及机制研究[J].中国生化药物杂志,2014,34(5):33-36. 被引量:5
  • 2李旭升,陈国荣,毛孙忠,雷康福,王芳,李安乐.银杏叶提取物对糖尿病大鼠膈肌的保护作用[J].中国病理生理杂志,2004,20(7):1234-1237. 被引量:12
  • 3徐敏,王芳,李旭升,毛孙忠,陈国荣,雷康福.香菇多糖对糖尿病大鼠膈肌线粒体的保护作用[J].中国应用生理学杂志,2006,22(2):240-242. 被引量:6
  • 4王芳,陈筱菲,陈国荣,李旭升,雷康福,毛孙忠.银杏叶提取物对糖尿病大鼠脂代谢及巨噬细胞功能的影响[J].中国病理生理杂志,2006,22(10):2036-2039. 被引量:12
  • 5DAY C P. Non-alcoholic fatty liver disease: a massive prob- lem[J]. Clin Med, 2011, 11(2): 176-178.
  • 6SUEN D F, NORRIS K L, YOULE R J. Mitochondrial dy- namics and apoptosis[J]. Genes Dev, 2008, 22(12): 1577- 1590.
  • 7SANTEL A, FULLER M T. Control of mitochondrial mor- phology by a human mitofusin[J]. J Cell Sci, 2001, ll4(Pt 5): 867-874.
  • 8KUO J J, CHANG H H, TSAI T H, et al. Curcumin amelio- rates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipo- apoptosis[J]. Int J Mol Med, 2012, 30(3): 643-649.
  • 9WU J, LI J, CAI Y, et al. Evaluation and discovery of novel synthetic chalcone derivatives as anti-inflammatory agents [J]. J Med Chem, 2011, 54(23): 8110-8123.
  • 10KARBOWSKI M, LEE Y J, GAUME B, et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drpl, and Mfn2 during apoptosis[J]. J Cell. Biol, 2002,159(6): 931-938.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部